Overview
Master Pharm is a contract manufacturer of dietary supplements, cosmetics, and medical products. The company offers comprehensive project implementation services for dietary supplements, from concept to product, and develops product documentation at every stage of product rollout. They assist clients with product notifications to relevant authorities.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2002-11-21. Active
07 1240 2656 1787 0010 7033 9173- 07 1240 5527 1978 0010 2676 7498
- 32 1240 5527 1787 0010 2676 7674
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jun 23, 2026 | Call to creditors |
Public aid
9 public aid cases recorded, with a total value of $1,570,880.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 4, 2021 | Regional investment aid | —— | Prezes Banku Gospodarstwa Krajowego | |
| May 8, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | —— | Polski Fundusz Rozwoju S.A. | |
| Dec 19, 2018 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | —— | Prezydent Miasta Łódź |
European Funds
5 projects co-financed from European Funds recorded, with total EU co-financing of $543,750.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-01-01 | Wdrożenie technologii innowacyjnej wegańskiej kapsułki miękkiej | $169.9K$169,863 | Program Operacyjny Inteligentny Rozwój | |
| 2018-10-01 | Opracowanie przez Master Pharm S.A. technologii chelatowania żelaza w celu poprawy jego biodostępności | $156.8K$156,812 | Regionalny Program Operacyjny Województwa Łódzkiego na lata 2014-2020 | |
| 2018-10-01 | Opracowanie przez Master Pharm S.A. technologii chelatowania magnezu | $144.0K$144,013 | Regionalny Program Operacyjny Województwa Łódzkiego na lata 2014-2020 |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | Waste generation | Active |
Authorized Representatives
Manner of representation
The following are authorized to represent the company and make declarations of will on behalf of the company: 1. in the case of a one-person management board, the President of the Management Board independently; 2. in the case of a multi-member management board, the President of the Management Board independently, two members of the management board jointly, or one member of the management board jointly with a commercial proxy.
Supervisory board
Beneficial owners
| Person | Rights | |
|---|---|---|
Wojciech Andrzej Furtak (46)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Oleofarmsp. z o.o. | $68,110,367.86 | oleofarm.pl | ||
| Zakłady Farmaceutyczne ColfarmS.A. | $27,692,749.78 | colfarm.pl | ||
| AKOS.A. | $25,706,868.29 | ako.com.pl | ||
| Global Pharma CmS.A. | $24,132,016.98 | globalpharma.pl | ||
| PolmassS.A. | $19,723,304.34 | polmass.eu | ||
| ALG Pharmasp. z o.o. | $16,237,368.88 | algpharma.pl | ||
| Laboratoria Naturysp. z o.o. | $13,931,403.39 | laboratorianatury.pl | ||
| Norsa Pharmasp. z o.o. | $9,111,390.60 | norsapharma.eu | ||
| Mipama E.Z.Szafarzsp. j. | $8,744,759.24 | mipama.pl | ||
| Gofarmsp. z o.o. + limited partnership | $8,632,148.10 | gofarm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2016-05-18 | Share capital change (185,000.00 PLN → 215,000.00 PLN) | |
| 2015-07-30 | Entered in the register |
FAQ
Last updated: 2026-08-20